mounjaro tirzepatide 15 mg injection

mounjaro tirzepatide 15 mg injection

Mounjaro 15 mg Injection contains Tirzepatide 15 mg, a once-weekly injectable medicine used to improve blood sugar control in adults with type 2 diabetes mellitus. It is also prescribed in certain cases to aid weight management in individuals with obesity or overweight when combined with diet and exercise.

Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It works by enhancing insulin release when blood sugar levels are high, lowering glucose production by the liver, and slowing digestion to reduce appetite and support weight loss.

Mounjaro 15 mg is administered subcutaneously in the abdomen, thigh, or upper arm, with rotation of injection sites each week. The 15 mg strength is typically prescribed after gradual dose escalation from lower strengths to minimize side effects.

Common side effects include nausea, vomiting, diarrhea, decreased appetite, and constipation. Serious risks may include pancreatitis or severe gastrointestinal issues. This medicine should not be used by individuals with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.